Data Sheet 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 3_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

ERI Thresholds Between Adjacent Zones. by Mingyue Sun (4638535)

“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”

Location of the study area. by Mingyue Sun (4638535)

“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”

Random Forest structure with cross-validation. by Mingyue Sun (4638535)

“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”

Land use change from 1990 to 2020. by Mingyue Sun (4638535)

“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”

Geographic data. by Mingyue Sun (4638535)

“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”

Classification accuracy. by Mingyue Sun (4638535)

“…The transition and desert zones decreased by 49.7% and 37.9%, respectively. The ERI decreased and was strongly correlated with the OLS. …”

SI Figure 1- uncropped western blots by Renata Goncalves (15806162)

Subjects:

Demographic data. by Narisa Rattanalert (21445983)

“…The participants practiced on the schematic eye as much as needed to feel confident in their skills. Mean rubric scores indicative of LIO-ROP skills significantly improved from 2.94 to 3.59 out of 4 (P < 0.001), and the time required for the laser procedure decreased from 17.19 to 15.14 minutes in pre- and post-LIO-ROP practice, respectively. …”

BFD2 exacerbates the inflammation induced in the acute stage of <i>T. gondii</i> infection. by Xiaocheng Zhang (3140460)

Subjects:

Length distribution and condition factors <i>K</i> of <i>E. erythropterus</i> (A) before and (B) after the NRE opening. by Jeong-Soo Gim (18058588)

Subjects:

Conceptual framework to guide the study. by Resham B. Khatri (10949429)

Subjects:

Correlation analysis, Data show only the values of the correlations that were significant (p < 0.05). by Glaucia Vilar-Pereira (686134)

a-d. Difference in (a) probing depth; (b) clinical attachment level; (c) bleeding on probing, and (d) plaque index values between baseline and six months after treatment using syst... by Iva Milinkovic (22331710)

Subjects:

BFD2 regulates anxiety-like behaviors induced by acute-stage <i>T. gondii</i> infection. by Xiaocheng Zhang (3140460)

Subjects:

BFD2 impacts pre-anxiety-like behaviors in the acute stage of <i>T. gondii</i> infection. by Xiaocheng Zhang (3140460)

Subjects:

Effect of DM, and/or <i>M. charantia</i> on the (I) number of corpuses lutea; (II) number of neonates, (III) weight of neonates; (IV) length of neonates levels in the control and d... by Amoura M. Abou-El-Naga (21001524)

Data. by Chao Zhang (51048)

Subjects:

Effect of DM, and/or <i>M. charantia</i> on the (I) glucose; (II) HOMA IR, (III) QUICKI levels; (IV) GLUT4; (V) AMPK; (VI) insulin; (VII) leptin levels in the control and different... by Amoura M. Abou-El-Naga (21001524)